Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Active, Not Recruiting

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

NCT03284385

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations

NCT03842228

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +5 more
Locations
  • Keck Medicine of USC Buena Park Buena Park, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors

NCT03030378

Conditions
Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

NCT04068194

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +24 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer

NCT04514497

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Yale University New Haven, Connecticut, United States
  • Smilow Cancer Hospital Care Center-Trumbull Trumbull, Connecticut, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02595931

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Colonic Diseases, +42 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC

NCT04606771

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Ciudad de Buenos Aires, Argentina
  • Research Site Delhi, India
View all 21 locations
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

NCT04784715

Conditions
Breast Cancer; HER2-positive; Metastatic, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Glendale, California, United States
  • Research Site Glendale, California, United States
View all 283 locations
View Trial Details
Active, Not Recruiting

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

NCT06506955

Conditions
Adenocarcinoma, Advanced/Metastatic Cancer, Carcinoma, +8 more
Locations
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Institut Paoli-Calmettes Marseille, France
  • Institut De Cancerologie Strasbourg Strasbourg, France
  • Severance Hospital Seoul, South Korea
View Trial Details

Related conditions